Lung & Thoracic

Datopotamab Deruxtecan Anchors Post-TKI Care in EGFR-Mutant Lung Cancer, MSK Oncologist Says

George Padron
Oncology Care, Biomarker & Genomic Testing, Specialty Medicine, Lung & Thoracic, Pulmonology | May 20, 2026
MSK's Helena Yu describes how datopotamab deruxtecan now anchors post-TKI care for EGFR-mutant lung cancer when no targetable resistance mechanism is found on re-biopsy

Advanced Cancer Treatment Creates New Reality of Living Long-Term With Terminal Disease

George Padron
Oncology Care, Breast Cancer, Hematologic Malignancies, GU Cancers, Lung & Thoracic, GI Cancers | Aug 27, 2025
Revolutionary cancer therapies enable patients to live years with terminal disease, requiring healthcare systems to adapt chronic care models.

Insurance Coverage Significantly Affects Cancer Patient Survival Rates with Immunotherapy

George Padron
Oncology Care, Breast Cancer, Hematologic Malignancies, GU Cancers, Lung & Thoracic, GI Cancers, Dermatologic Cancer | Aug 13, 2025
A study of 183,440 cancer patients shows insurance coverage significantly affects immunotherapy survival outcomes, with uninsured patients lagging behind.

Lung & Thoracic

Datopotamab Deruxtecan Anchors Post-TKI Care in EGFR-Mutant Lung Cancer, MSK Oncologist Says

Advanced Cancer Treatment Creates New Reality of Living Long-Term With Terminal Disease

Insurance Coverage Significantly Affects Cancer Patient Survival Rates with Immunotherapy

Latest News

Mapping Parkinson's Genetics Beyond European Ancestry

Putting a Price on Exercise After Colon Cancer Treatment

AI for Managed Care Administration: Enhancement or Replacement? (Part 2)

A Bispecific Moved Earlier in Myeloma, and Brought Its Infection Risk With It

A Blood Test's Blind Spots: Discrepancies Between P-tau217 and Clinical Alzheimer's Disease

Who We Are

Connect